Stock TMDX TRANSMEDICS GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News TransMedics Group, Inc.

Equities

TMDX

US89377M1099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
87.24 USD -0.71% Intraday chart for TransMedics Group, Inc. -7.14% +10.53%
Apr. 18 Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing MT
Apr. 05 Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing
MT
TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024
PR
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR
Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing
MT
Transmedics Group Insider Sold Shares Worth $1,110,150, According to a Recent SEC Filing
MT
Piper Sandler Initiates TransMedics Group With Overweight Rating, $95 Price Target
MT
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR
TMDX INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX
PR
TransMedics to Present at Upcoming March Investor Conferences
PR
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR
Oppenheimer Adjusts TransMedics Group Price Target to $105 From $92, Maintains Outperform Rating
MT
Top Premarket Gainers
MT
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX
BU
TransMedics: Q4 Earnings Snapshot
AQ
Transcript : TransMedics Group, Inc., Q4 2023 Earnings Call, Feb 26, 2024
TransMedics Group Swings to Net Income in Q4, Revenue Increases; Sets 2024 Revenue Outlook-- Shares Rise
MT
TransMedics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
TransMedics Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
PR
Earnings Flash (TMDX) TRANSMEDICS GROUP Posts Q4 Revenue $81.2M, vs. Street Est of $68.5M
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TMDX Stock
  4. News TransMedics Group, Inc.